SCHEMBL649418

SCHEMBL649418

COc1cncc(N2C[C@H]3CCN(C(=O)OC(C)(C)C)C[C@H]32)c1

nearest known ligand 0.53

Predicted protein targets (top 9)

geneUniProtsupporting neighboursconfidence
CHRNB2 P17787 6/20 0.53
CHRNB4 P30926 6/20 0.53
CHRNA3 P32297 6/20 0.53
CHRNA4 P43681 6/20 0.53
GPR119 Q8TDV5 10/20 0.50
ALDH1A1 P00352 1/20 0.47
PDE4B Q07343 1/20 0.44
HTT P42858 1/20 0.43
USP30 Q70CQ3 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3579980 0.86 CHRNB2 (0.58) CHRNB2CHRNB4CHRNA3CHRNA4
SCHEMBL652005 0.84 CHRNB2 (0.52) CHRNB2CHRNB4CHRNA3CHRNA4GPR119
SCHEMBL650042 0.84 CHRNB2 (0.52) CHRNB2CHRNB4CHRNA3CHRNA4GPR119
SCHEMBL649855 0.83 GPR119 (0.69) CHRNB2CHRNB4CHRNA3CHRNA4GPR119
SCHEMBL649395 0.83 GPR119 (0.69) CHRNB2CHRNB4CHRNA3CHRNA4GPR119
SCHEMBL652471 0.80 GPR119 (0.47) GPR119USP30
SCHEMBL653184 0.79 CHRNB2 (0.49) CHRNB2CHRNB4CHRNA3CHRNA4GPR119
SCHEMBL650797 0.79 CHRNB2 (0.47) CHRNB2CHRNB4CHRNA3CHRNA4GPR119
SCHEMBL652111 0.79 CHRNB2 (0.49) CHRNB2CHRNB4CHRNA3CHRNA4GPR119
SCHEMBL654584 0.79 CHRNB2 (0.47) CHRNB2CHRNB4CHRNA3CHRNA4GPR119

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8119635-B2 Diazabicyclic central nervous system active agents ABBOTT LABORATORIES (US) 2012-02-21 US disclosed
EP-2298775-A1 Diazabicyclic central nervous system active agents Abbott Laboratories (US) 2011-03-23 EP disclosed
EP-2295437-A1 Diazabicyclic central nervous system active agents Abbott Laboratories (US) 2011-03-16 EP disclosed